Zhejiang XinNong Chemical Co.,Ltd. (SHE:002942)
China · Delayed Price · Currency is CNY 21.35
+0.16 (0.76%)
Feb 6, 2026, 3:04 PM CST
Zhejiang XinNong Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,013 | 931.18 | 798.53 | 1,213 | 1,119 | 1,176 |
Other Revenue | 31.09 | 31.09 | 22.5 | 35.55 | 43.17 | 17.9 |
| 1,044 | 962.27 | 821.03 | 1,248 | 1,163 | 1,194 | |
Revenue Growth (YoY) | 14.08% | 17.20% | -34.22% | 7.36% | -2.61% | 9.91% |
Cost of Revenue | 729.9 | 702.45 | 652.01 | 933.7 | 807.36 | 826.51 |
Gross Profit | 313.73 | 259.81 | 169.03 | 314.47 | 355.21 | 367.17 |
Selling, General & Admin | 163.38 | 147.13 | 153.12 | 148.65 | 140.3 | 111.18 |
Research & Development | 56.47 | 56.82 | 58.33 | 70.24 | 75.72 | 62.38 |
Other Operating Expenses | 1.84 | 1.21 | 7.59 | 6.68 | 5.71 | 7.74 |
Operating Expenses | 222.47 | 207.12 | 216.38 | 227.02 | 221.69 | 181.66 |
Operating Income | 91.26 | 52.69 | -47.36 | 87.45 | 133.52 | 185.51 |
Interest Expense | -0.22 | -0.16 | -0.1 | -0.14 | -2.15 | -1.82 |
Interest & Investment Income | 13.14 | 14.69 | 8.46 | 5.76 | 21.61 | 21.79 |
Currency Exchange Gain (Loss) | 2.79 | 2.79 | 2.38 | 11.86 | -2.3 | -7.7 |
Other Non Operating Income (Expenses) | -6.8 | -2.3 | -0.59 | 0.71 | -0.84 | -3.27 |
EBT Excluding Unusual Items | 100.17 | 67.7 | -37.2 | 105.65 | 149.84 | 194.51 |
Gain (Loss) on Sale of Investments | 5.45 | 2.47 | 4.49 | -3.93 | 1.35 | 1.4 |
Gain (Loss) on Sale of Assets | -0.82 | -0.74 | 0.34 | 0.11 | -0.2 | 0.18 |
Asset Writedown | -14.13 | -15.27 | -7.1 | -0.18 | -1.05 | -0.84 |
Legal Settlements | -0.56 | -0.56 | - | - | - | - |
Other Unusual Items | 9.03 | 8.9 | 9.11 | 8.38 | 3.23 | 3.15 |
Pretax Income | 99.13 | 62.5 | -30.36 | 110.04 | 153.16 | 198.4 |
Income Tax Expense | 12.46 | 4.77 | -4.98 | 8.64 | 15.29 | 23.16 |
Net Income | 86.67 | 57.73 | -25.37 | 101.4 | 137.87 | 175.24 |
Net Income to Common | 86.67 | 57.73 | -25.37 | 101.4 | 137.87 | 175.24 |
Net Income Growth | 222.10% | - | - | -26.46% | -21.32% | 13.41% |
Shares Outstanding (Basic) | 153 | 152 | 149 | 154 | 157 | 156 |
Shares Outstanding (Diluted) | 153 | 152 | 149 | 154 | 157 | 156 |
Shares Change (YoY) | 3.12% | 1.78% | -2.84% | -1.94% | 0.13% | 0.48% |
EPS (Basic) | 0.57 | 0.38 | -0.17 | 0.66 | 0.88 | 1.12 |
EPS (Diluted) | 0.57 | 0.38 | -0.17 | 0.66 | 0.88 | 1.12 |
EPS Growth | 212.36% | - | - | -25.00% | -21.43% | 12.87% |
Free Cash Flow | 99.24 | 108.91 | 19.07 | 42.67 | 84.46 | 53.63 |
Free Cash Flow Per Share | 0.65 | 0.72 | 0.13 | 0.28 | 0.54 | 0.34 |
Dividend Per Share | 0.300 | 0.300 | 0.200 | 0.250 | 0.500 | 0.231 |
Dividend Growth | 50.00% | 50.00% | -20.00% | -50.00% | 116.64% | -34.06% |
Gross Margin | 30.06% | 27.00% | 20.59% | 25.20% | 30.55% | 30.76% |
Operating Margin | 8.74% | 5.47% | -5.77% | 7.01% | 11.48% | 15.54% |
Profit Margin | 8.30% | 6.00% | -3.09% | 8.12% | 11.86% | 14.68% |
Free Cash Flow Margin | 9.51% | 11.32% | 2.32% | 3.42% | 7.27% | 4.49% |
EBITDA | 144.18 | 104.09 | 2.03 | 133.07 | 174.53 | 218.03 |
EBITDA Margin | 13.81% | 10.82% | 0.25% | 10.66% | 15.01% | 18.27% |
D&A For EBITDA | 52.91 | 51.4 | 49.39 | 45.62 | 41.01 | 32.52 |
EBIT | 91.26 | 52.69 | -47.36 | 87.45 | 133.52 | 185.51 |
EBIT Margin | 8.74% | 5.47% | -5.77% | 7.01% | 11.48% | 15.54% |
Effective Tax Rate | 12.57% | 7.63% | - | 7.85% | 9.98% | 11.67% |
Revenue as Reported | 1,044 | 962.27 | 821.03 | 1,248 | 1,163 | 1,194 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.